Coller Capital

Coller Capital, established in 1990, is a London-based investment firm specializing in direct and secondary investments in private equity. It focuses on providing liquidity to investors seeking to exit early from their private equity investments, including Limited Partner positions in funds or portfolios of direct investments in companies. The firm invests globally, with a particular focus on the Asia, Europe, Middle East, and North America regions. Its investment size varies widely, from $1 million to over $1 billion, typically taking minority stakes in medium-sized companies. Coller Capital exits investments primarily through initial public offerings or trade sales within four to six years.

François Aguerre

Partner, Co-Head of Investment and Global Head of Origination

Jeremy Coller

Managing Partner and Chief Investment Officer

Eric Foran

Partner, Investment

Jon Freeman

Partner, Investment

Ed Goldstein

Partner, CIO of Coller Credit Secondaries

David Jolly

Partner, Investment

Peter Kim

Partner and Head of Asia

Paul Koffel

Partner, Execution

Paul Lanna

Partner, Investment

Martins Marnauza

Partner, Investment

Rune Munk

Partner, Investment

Peter Rosen

Partner, Execution

Michael Schad

Partner and Head of Coller Credit Secondaries

8 past transactions

Zepz

Series F in 2024
Zepz is an online money transfer service that enables individuals to send money to friends and family living abroad through computers, smartphones, or tablets. It provides a convenient and cost-effective alternative to traditional money transfer companies, which often charge high fees. Zepz allows users to send funds to over 140 destinations worldwide, including Europe, Asia, Africa, Australia, and the Americas. Recipients can receive money as bank deposits, cash pickups, Mobile Money, or mobile airtime top-ups. The platform is designed to facilitate secure international transfers, utilizing technology that allows customers to manage their funds efficiently, with lower processing fees compared to conventional methods. Zepz operates in 50 countries, aiming to simplify the process of remittance for its users.

IntelePeer

Venture Round in 2024
IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

Ssangyong C&E

Private Equity Round in 2022
SsangYong C&E is a private cement manufacturer based in South Korea, known for its significant contributions to the local cement industry through technological innovation and quality enhancement. The company operates manufacturing facilities in Donghae and Yeonwol, producing a range of products including Portland cement, blended cement, specialty cement, and mortar. In addition to cement production, SsangYong C&E is involved in waste recycling and other environmentally related businesses, as well as the sale of petroleum products. The firm is distinguished by having established the first independent technology research center in its sector, underscoring its commitment to advancing industry standards.

Exterro

Private Equity Round in 2022
Exterro, Inc. is a provider of e-discovery and information governance software solutions focused on the legal and IT markets, serving Fortune 500 corporations as well as law firms and government agencies. Founded in 2004 and headquartered in Beaverton, Oregon, the company offers the Fusion Platform, which integrates with existing enterprise technologies to connect stakeholders such as legal, IT, records management, and compliance teams. Exterro’s solutions include E-Discovery Data Mapping for creating data maps of electronically stored information, Legal Hold for compliance with privacy laws, and E-Discovery Data Management for collection and review processes. Additionally, it provides project management tools for legal teams, a case law library for reference, and cloud-based e-discovery software. The company's offerings aim to enhance collaboration, mitigate risks, and streamline legal processes, thereby enabling organizations to better manage governance, risk, and compliance challenges.

Hoxton Farms

Seed Round in 2020
Hoxton Farms, based in London, UK, specializes in producing real animal fat without the use of animals. The company employs cell biology and advanced mathematical modeling to cultivate purified animal fat in bioreactors, catering primarily to the meat alternatives industry. This innovative approach enables the creation of cruelty-free fat that can be utilized not only in meat alternatives but also in other sectors such as bakery, confectionery, and cosmetics. By focusing on sustainable and ethical production methods, Hoxton Farms aims to transform the way fat is sourced and used in various products.

BOOK A TIGER

Series B in 2017
BOOK A TIGER is an integrated facility management platform that focuses on providing high-quality home cleaning services. Through its online booking system, customers can easily access a range of cleaning solutions offered by a network of connected partners. The platform aims to streamline the booking process, ensuring that users receive reliable and professional cleaning services tailored to their needs. By leveraging technology, BOOK A TIGER enhances convenience for customers seeking efficient home maintenance options.

uniQure

Private Equity Round in 2013
uniQure is a pioneering gene therapy company recognized for developing the first gene therapy product to receive regulatory approval in the European Union. Its initial product, Glybera, was authorized in October 2012 for treating patients with lipoprotein lipase deficiency, a rare and severe metabolic disorder. uniQure specializes in creating innovative gene therapies that offer long-term and potentially curative benefits for genetic and acquired diseases. The company utilizes a modular technology platform and a proprietary manufacturing process to develop its treatments. Currently, uniQure is expanding its pipeline of adeno-associated virus (AAV)-based gene therapies, focusing on conditions such as hemophilia, Huntington's disease, and cardiovascular diseases through collaborations, including one with Bristol Myers Squibb. While the company initially targets orphan diseases, it also aims to address chronic and degenerative diseases affecting larger populations.

Societe Innovatech du Grand Montreal

Acquisition in 2004
Societe Innovatech du Grand Montreal
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.